Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Changlin Li

5PUBLICATIONS

5CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 26, 2026

Alternol-Induced Oxidative Modification of SQSTM1/p62 Is Associated with Nrf2 Signaling and Autophagy-Related Responses in Prostate Cancer Cells.

|Sep 19, 2025

MIF Facilitates Resistance to Androgen Deprivation Therapy by Regulating AMPD2 Expression in Prostate Cancer Cells.

Changying Li, Chenchen He, Jiancheng Pan

|Aug 05, 2021

Alternol triggers immunogenic cell death <i>via</i> reactive oxygen species generation.

Changlin Li, Ying Zhang, Siyuan Yan

|Nov 20, 2020

Proteasome inhibitors attenuates mitoxantrone-triggered immunogenic cell death in prostate cancer cells.

Wei Wei, Haibin Li, Guoan Zhang

|Jul 26, 2020

Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression.

Changlin Li, Hui Sun, Wei Wei

Pageof 1

Frequent Collaborators

2 joint publications

Benyi Li

1 joint publications

Yuhong Feng

1 joint publications

Wang Liu

1 joint publications

Ruibao Chen

1 joint publications

Cuncong Zhong

Frequent Collaborators

2 joint publications

Benyi Li

1 joint publications

Yuhong Feng

1 joint publications

Wang Liu

1 joint publications

Ruibao Chen